| Application no. and date | 13837458.2 (espacenet) (Federated) (European Patent Register), 20130917 | | Patent/reg. no. and date | DK/EP 2900061, 20200122 | | Publication date | 20150805 | | Priority no. and date | US 201261701914 P, 20120917, US 201361756818 P, 20130125, US 201361759532 P, 20130201 | | EP pub. no. and date |
EP 2900061 20150805 | | Effective date | | | Applicant/owner | Galectin Therapeutics Inc., 4960 Peachtree Industrial Blvd.
Suite 240
Norcross, GA 30071, US,
Providence Health & Services Oregon d/b/a Earle A.
Chiles Research Institute of the Robert W. Franz
Cancer Res. Cent. at Providence Port. Med. Cen., 4805 NE Gilsan Street, 2N35
Portland, OR 97213, US | | Applicant ref. no. | V2002-018-DK | | Inventor | KLYOSOV, Anatole, 36 Walsh Road
Newton, MA 02459, US,
ZOMER, Eliezer, 374 Kenrick Street
Newton, MA 02459, US,
TRABER, Peter, G., 5272 Lacosta Lane
Johns Creek, GA 30022, US,
LINCH, Stefanie, N., 4805 NE Gilsan Street, 2N35
Portland, OR 97213, US,
REDMOND, William,L., c/o Earle A. Chiles Research Institute
Providence cancer Center
4805 NE Gilsan Street, 2N35
Portland, Oregon 97213, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A01N 43/04 (2006.01) , C07H 15/04 (2006.01) | | Title | FREMGANGSMÅDE TIL FORSTÆRKNING AF SPECIFIKKE IMMUNTERAPIER VED CANCERBEHANDLING | | Int. application no. | US2013060182 | | Int. publication no. | WO2014043708 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
